Flu jabs have long been available to fight off the seasonal virus, but their rate of effectiveness can vary from between 40 percent and 70 percent.
ADVERTISEMENT
They work by injecting an inactivated virus strain into humans to trigger immunity. That inactivated virus must be prepared well in advance, and this can cause problems if the strains don’t match up.
But now drugmakers and laboratories are rushing to apply what has been learned about RNA jabs to the flu, motivated by the potential not only for more effective, life-saving vaccines but also the vast profits up for grabs.FEATURED STORIES
NEWSINFO
Atienza tells Bongbong: You’re not a millennial to be ignorant of martial law atrocities
NEWSINFO
PH’s ‘bloodiest killing field’ not on DOJ list of drug campaign killings
NEWSINFO
Matibag calls Senate budget hearing ‘political,’ gets kicked out
RNA, or ribonucleic acid, is the lesser-known cousin of DNA, or deoxyribonucleic acid, the building block of genes.
Last month US pharmaceutical firm Pfizer began injecting humans with a flu vaccine that uses messenger RNA (or mRNA), which it already uses in its coronavirus vaccine.
Recommended videosPowered by AnyClip1/7North Korea says US overreacting over missile testRead More
18.6K
6
Video Player is loading.Play VideoUnmuteDuration /Current Time Playback Speed Settings1xLoaded: 0%Remaining Time - FullscreenPlayUp NextThis is a modal window.Beginning of dialog window. Escape will cancel and close the window.TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaqueFont Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall CapsReset restore all settings to the default valuesDoneClose Modal DialogEnd of dialog window.Playback Speed0.25x0.5x1x Normal1.5x2xReplay the listPowered by AnyClip Privacy Policy
TOP ARTICLES
North Korea says US overreacting over missile test
NOW PLAYING
UP NEXT
Ethiopia hits Tigray's capital with third airstrike
NOW PLAYING
UP NEXT
Isko Moreno promises to cut tax on fuel, electricity by 50%
NOW PLAYING
UP NEXT
WATCH: OCEAN PARK SA MANILA, BUKAS NA | CHONA YU
NOW PLAYING
UP NEXT
WATCH: MGA MAGSASAKA, UMAARAY NA SA SMUGGLING NG GULAY NA GALING CHINA | CHONA YU
NOW PLAYING
UP NEXT
WATCH: MGA MAGSASAKA, SUMUGOD SA MENDIOLA | CHONA YU
NOW PLAYING
UP NEXT
Atienza: Makabayan endorses Pacquiao
NOW PLAYING
UP NEXT
North Korea says US overreacting over missile test
Moderna, a US biotech company that makes a rival COVID-19 vaccine using mRNA, launched its own flu jab trials in July.
And French drugmaker Sanofi has started trials on a “monovalent” RNA vaccine – which means it targets a single strain of the virus – and will begin trials on a “quadrivalent” vaccine next year.
95-percent effective?
Immunologist Claude-Agnes Reynaud said that six months before flu season—“we assess which strains are circulating the most.”
“Sometimes we get it wrong, and this creates a significant excess of mortality,” said the director of research at France’s INSERM health and medical research institute.
“The problem with inactivating a virus to prepare a vaccine is that it can damage certain surface proteins,” she added—and it is those same proteins that trigger the immune response.
ADVERTISEMENT
Instead of carrying these virus proteins into the body, lab-generated mRNA tells human cells to create them, so that the immune system can recognize and fight future infection.
The World Health Organization advises vaccine makers on which strain of flu they should track.
“And if it warns of a change in the prevalent strains, we will be able to change much faster with RNA” technology, said Jean-Jacques Le Fur, an analyst at Bryan, Garnier & Co. —AFP
.inline_ffff input { width: 70%!important; }
.bypro {
float: right;
width: 71%;
text-align: center;
margin-top: -12px;
margin-right: 15px;
clear: both;
color: #5C5C5C;
font-size: 8px!important;
line-height: 9px!important;
}
.lfform-inquirer-horizontal h2 {
font-weight: bold !important;
font-family: mallory !important;
}
@media only screen and (min-width: 360px) and (max-width: 767px) {
.lfform-inquirer-horizontal #myForm3 {
width: 100%;
display: flex;
flex-wrap: wrap;
justify-content: center;
}
.lfform-inquirer img {
width: 100% !important;
margin: 0 !important;
}
.bypro {
margin-top: 10px;
}
.lfform-inquirer-horizontal input[type=""email""] {
width: 100% !important;
}
.lfform-inquirer-horizontal input[type=""submit""], .lfform-inquirer-horizontal input[type=""button""] {
width: 100% !important;
}
}
.formv4 {
width: 100%!important;
max-width: 100%;
margin: 15px 0;
}
.formv4 input[type=""email""] {
font-weight: bold;
float: left;
-webkit-appearance: none;
margin: 0!important;
width: 70% !important;
}
.formv4 input[type=""submit""] {
font-weight: bold;
width: 28% !important;
padding: 3%;
float: left;
-webkit-appearance: none;
}
.formv4 #myForm3 {
width: 100%;
display: flex;
flex-wrap: wrap;
justify-content: space-between;
}
.formv4 .bypro {
width:100%;
font-family: 'noto serif';
float: unset;
clear: both;
color: #333333;
font-size: 11px!important;
line-height: 1 !important;
margin: 10px 3px;
text-align:left;
}
.formv4 a, .formv4 a:visited, .formv4 a:hover {
color: #0b72b5 !important;
text-decoration: none; !important;
}
.formv4 h2 {
font-weight: bold !important;
text-align: left;
font-family: mallory !important;
color: #333333 !important;
margin:5px 0 !important;
padding: 0 !important;
}
.formv4 p {
width: 100%;
text-align: left;
color: #5A5A5A !important;
font-family: 'noto serif' !important;
font-size: 14px !important;
margin: 0 !important;
line-height: 1.6em !important;
margin-bottom: 15px !important;
padding: 0 !important;
}
@media only screen and (min-width: 360px) and (max-width: 767px) {
.formv4 h2 {
font-size: 16px !important;
}
.formv4 .bypro {
font-size: 12px!important;
margin: 5px 5px;
}
.formv4 input[type=""email""] {
width: 100% !important;
}
.formv4 input[type=""submit""] {
width: 100% !important;
margin: 10px 0;
}
.formv4 {
width: 95%!important;
max-width: 95%;
margin: 20px auto;
}
}
Subscribe to our daily newsletter
By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.
For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .
#inqplus-article2 {
width: 100%;
height: 250px;
margin: 20px auto;
background-color: #a5b8c5;
display: flex;
flex-wrap: wrap;
justify-content: space-between;
align-items: flex-start;
}
#inqplus-cta-wrap {
width: 50%;
height: 250px;
background-image: url(/single2017/images/inqplus-sub/inqplus-cta-bg1.png);
background-repeat: no-repeat;
background-size: cover;
}
#inqplus-cta2 {
width: 89%;
height: auto;
margin: 35px auto 0;
}
#inqplus-cta2 img {
width: 100%;
}
#newsletter-cta-wrap {
width: 50%;
height: 250px;
background-image: url(/single2017/images/inqplus-sub/newsletter-bg1.png);
position: relative;
background-repeat: no-repeat;
background-size: cover;
}
#newsletter-cta2 {
width: 95%;
position: absolute;
bottom: -4px;
z-index: 1;
}
#newsletter-cta2 img {
width: 100%;
}
#inqplus-nl-sub2 {
width: 65%!important;
display: flex;
font-size: 0;
box-sizing: border-box;
z-index: 2;
position: absolute;
bottom: 10px;
right: 10px;
}
#inqplus-nl-sub2 form {
width: 100%!important;
}
.sub-input2 {
width: 70%!important;
height: 25px!important;
border: 0!important;
padding: 5px 0 5px 10px!important;
margin: 0!important;
box-sizing: border-box!important;
border-radius:0;
-webkit-appearance:none;
}
.sub-btn2 {
width: 30%!important;
height: 25px!important;
border: 0!important;
padding: 0!important;
margin: 0!important;
background-color: #004a87!important;
color: #f5f5f5!important;
text-transform: uppercase!important;
border-radius:0;
-webkit-appearance:none;
}
/* 414px */
@media only screen and (min-width: 414px) and (max-width: 599px){
#inqplus-article2 {
width: 98%;
height: auto;
}
#inqplus-cta-wrap {
width: 100%;
height: auto;
}
#newsletter-cta-wrap {
width: 100%;
}
#newsletter-cta2 img {
width: 90%;
}
}
/* 320px */
@media only screen and (min-width: 320px) and (max-width: 413px){
#inqplus-article2 {
width: 98%;
height: auto;
}
#inqplus-cta-wrap {
width: 100%;
}
#newsletter-cta-wrap {
width: 100%;
}
}
Read Next
Clinical trial of China-made jab in Cebu City alarms exec
VerrulonRemove Warts & Skin Tags Safely At Home! Try Out Now!Verrulon|SponsoredSponsoredUndoTips and Tricks[Gallery] Teenage pole vaulter's life is almost ruined after pictures go viralTips and Tricks|SponsoredSponsoredUndoArticles SkillDean Martin's Daughter Finally Confirms the RumorsArticles Skill|SponsoredSponsoredUndoBETER - leading providerSports betting odds, api for sportsbooksBETER - leading provider|SponsoredSponsoredUndoHappy in ShapeBoy is bullied at a Burger King. The reaction of the other customers is amazing!Happy in Shape|SponsoredSponsoredUndoAtlantic MirrorJada Pinkett Smith Revealed How She Really Felt After Her Son's Sudden DecisionAtlantic Mirror|SponsoredSponsoredUndoTips and TricksA Marine rushes home to greet his wife, but is surprised when he sees her.Tips and Tricks|SponsoredSponsoredUndo
window._taboola = window._taboola || [];
_taboola.push({
mode: 'thumbnails-d',
container: 'taboola-below-article-thumbnails-desktop',
placement: 'Below Article Thumbnails - newsinfo',
target_type: 'mix'
});
window._taboola = window._taboola || [];
_taboola.push({
mode: 'thumbnails-e',
container: 'taboola-below-article-thumbnails-mobile',
placement: 'Below Article Thumbnails - newsinfo',
target_type: 'mix'
});
EDITORS' PICK
PH’s ‘bloodiest killing field’ not on DOJ list of drug campaign killings
Atienza tells Bongbong: You’re not a millennial to be ignorant of martial law atrocities
Leaked: A 60x Zoom and all-new Helio G96 mean a complete overhaul for TECNO Mobile’s new CAMON 18 series
Delivering delight against all odds
Duterte blasts rights groups for overlooking the ‘other side’ of drug war
Next level mobile photography within reach with vivo X70 co-engineered with ZEISS
MOST READ
Atienza tells Bongbong: You’re not a millennial to be ignorant of martial law atrocities
PH’s ‘bloodiest killing field’ not on DOJ list of drug campaign killings
Robredo to supporters: Be calm, gentle and do good deeds
Matibag calls Senate budget hearing ‘political,’ gets kicked out
Don't miss out on the latest news and information.
View comments" - https://www.affordablecebu.com/
